资源描述
2021.12 iResearch Inc.2 iResearch I 2020 260.1 29.4%2023 589.7 SMS 1 2 3 3 iResearch I 4 1 2 3 45 iResearch I iResearch I2222.02513.72619.02992.23400.21995.92461.98.4%13.1%4.2%14.2%13.6%2016 2017 2018 2019 2020 2020.8 2021.8%2020 29.8%Euromonitor 68.4%14.8%7.4%NA 5.4%4.0%2015 41.0%29.8%8.7%9.4%5.8%5.3%2020 23.3%2016-2021 8 6 iResearch I 2017 4 14.2%72.1%64.3%36.1%2017 2017 1 31 1 No.1No.2No.3No.4 72.1%14.2%13.7%2017 64.3%35.7%20177 iResearch I iResearch I 80%ISBN 978-7-117-26472-3 Kline PC Active 2020 2020 B A C E 80%8 iResearch I Albert M.Kligman Cosmeceutical Cosmetics Pharmaceuticals Kligman/9 iResearch I+=+=FD&C Act EC 1223/2009/Quasi drug FDA Official Journal of the European Union OTC OTC 3 2 1 10 iResearch I 2010 2019 2010 2010 2010 2010 2007 2008 2010 2019 11 iResearch I 2020 1 727 VS12 iResearch I 2020 4 2020 4 2021 1 1 5 3 2022 1 1,2020 2021 1 2021 5 2020 4 HCl PEG-23-200 4 2020 6 2021 1 1 1989 30 2021 1 2021 5 1 3 2020 2020 4 2021 4 2022 1 1 2022 1 13 iResearch I iResearch I1998-2011 2011 1998 2011 2 Euromonitor 68.3%6.0%3.6%22.1%1998 2001 2003 2007 2011 2005 2004 2011 50%14 iResearch I 2021 Wind 1995 2010 2015 2020 A 43+IPO A 24 500 1150 A IPO A 30 IPO A 7 83+31%500 A 5000 KIP A+1500 B 2000 6+15 iResearch I iResearch I2016 2020 2016 2020 2016 20.8%2020 35.3%Euromonitor Euromonitor 24.5%20.8%16.1%15.6%8.6%7.4%5.4%0.9%0.6%35.3%22.1%16.1%8.6%6.3%6.3%4.2%0.8%0.4%16 iResearch I OEM/ODM ODM C 2021 60-80%1.OEM Original Equipment Manufacture 2.ODM Original Design Manufacturer 2021 OEM ODM OEM ODM 50-60%OEM 10-15%ODM 45-55%20-45%50-70%25-45%C 60-80%C 17 iResearch I OEMODM 18 1 2 3 419 iResearch I iResearch I 71.5%28.5%1.8%8.4%33.0%50.9%6.0%0.6%2.5%23.9%65.0%8.0%=56 46-55 36-45 26-35=25 2-3/1/2/2021 2021+70%65%26-35 26-45 80%26-35 N=1000 2021 9 iClick N=1000 2021 9 iClick20 iResearch I iResearch I 80%80.3%76.8%800-1500 300-500 58.4%52.3%N=1000 2021 9 iClick N=1000 2021 9 iClick 2021 81.9%76.0%48.3%46.2%36.6%74.9%70.8%55.7%42.5%37.4%79.3%80.3%-76.8%2021 3.6%12.3%19.0%21.4%20.8%14.1%4.9%3.8%11.2%26.3%18.3%16.5%14.0%7.4%4.6%1.8%58.4%52.3%21 iResearch I iResearch I29.0%31.7%42.4%44.5%48.4%48.5%2021 N=1000 2021 9 iClick N=1000 2021 9 iClick 2021 43.0%42.7%40.7%40.0%38.4%37.6%28.1%44.2%45.0%46.7%40.6%38.5%35.2%25.6%40.0%36.8%25.6%38.6%38.3%43.5%34.4%22 iResearch I iResearch I2021 2021 41%47.8%40.7%11.5%N=1000 2021 9 iClick N=1000 2021 9 iClick 42.2%42.0%37.8%35.4%34.6%31.7%31.0%41%47.8%40.7%11.5%47.8%40.7%23 iResearch I iResearch I2021 2021/60%N=1000 2021 9 iClick N=1000 2021 9 iClick 0.7%22.6%31.1%39.5%52.6%59.1%65.9%70.7%56.9%47.7%&53.6%43.1%37.6%24 iResearch I iResearch I2021/NPS61.6%22.6%14.7%0.9%0.2%&NPS 50.0%48.8%73.7%N=1000 2021 9 iClick N=1000 2021 9 iClick 67.3%16.6%14.3%1.5%0.3%NPS=48.8%NPS=50.0%73.7%69.2%65.8%65.8%/48.2%25 iResearch I 74.297.8129.4198.0260.1352.3459.2589.731.9%32.2%53.1%31.3%35.5%30.3%28.4%2016 2017 2018 2019 2020 2021e 2022e 2023e2016-2023%CAGR=36.8%2018 2019 2020 2020 260.1 29.4%2023 589.7CAGR=29.4%Euromonitor 26 1 2 3 427 iResearch I iResearch I 1909 1963 1963(ENXTPA:OR)1963-1983 1909-1962 1984-2005 2006-28 iResearch I-20.0%0.0%20.0%40.0%-20.0%0.0%20.0%40.0%2020 2019 2020 10.0%19 20 2020 2019 8.9%2020 10.8%2020=-2019+17.1%2020+13.0%2019+17.6%2020-7.6%2019+6.0%2020-8.2%2019+5.5%2020-10.0%2019 2020 36.9%36.4%2019-2020 8.9%10.8%2019-2020 11.5%11.1%2019-2020 42.7%41.8%2019-2020 2019 2020 2020 25.4%22.4%20.4%18.8%(1)29 iResearch I 2020 1928 B5 K 67-345 20.0 1931 VC 89-371 10.0 1974 150-780 1652.1 1 1997 C 300-1760 11.3 2005 C 52-160 2.1 2020 2016 1.3%2020 6.9%1.Euromonitor 30 iResearch I iResearch I 2010 2020 90%2017 2020 99%2020H1 14%2020 22.5%2015 A Euromonitor 6.7%10.5%13.1%17.0%20.2%22.5%2015 2016 2017 2018 2019 20202015-2020%No.6No.4No.2No.2No.1 No.1 2020 H1 2017-2020 32%14%99%+2020 89.5%7.4%2.5%31 iResearch I C 2014 2019 46 11 2.9 4.6 5.4 6.9 6485951042017 2018 2019 20202017-2020 62.1%71.7%76.7%83.2%17.2%20.3%25.1%30.8%2017 2018 2019 20202017-2020%32 iResearch I 192009 2009-2013 2003 2009 2013 2014-2018 2014 2017-2018-2019-2019-SKU 14 5 3 8 1 1 1 PBS P-FOS Refractance Window 98%+P-FOS 2009 2013 2018 2018 2018 2019 20212020 31.4%33 iResearch I iResearch I 2019 2020 Q1 500%10 GMV 150%2021 618 Top3 2020 CNP Euromonitor 618 Euromonitor 1.7%2.3%2.7%3.0%2.9%6.0%2015 2016 2017 2018 2019 20202015-2020%2020 GMV2021 618 TOP3 2019 2021 2021 2021 2019-2020 Q1 500%34 iResearch I 2000 7 2012 2016 2021 2000 2007 2011 CEP DMF 2012 2016 2017 Revitacare2019 11 6 A 2020 6 2018 2021&35 iResearch I iResearch I SKU&4D+B12&KOL V 3D 2021 6 30 126467 36 iResearch I iResearch I 2020 50%2021 1 158%360%2021 11 11/2016 25.8%2020 49.0%2020 36.0%37 iResearch I 2010 2010&15 17+15+3+/200+300+2000+38 iResearch I 2019-2020 4 2020 5 2019 2021 11 50 2021 COSMO/FulHol-2020-*-2020-Frapertide PMS-003-FulQun-2013-6:4-FULFIL-2018-,-FORENEE-2016-OPC-2021 11 TOP3 2021 11 50 2021 ELLE 39 1 2 3 440 iResearch I 2020 2021 2 41 iResearch I APP APP 42 iResearch I 2021 65%N=1000 2021 9 69.2%65.8%65.8%48.2%47.1%/2021 43 iResearch I/44 IPO 45 2002 3000 400-026-Contact Us 46
展开阅读全文